SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-084900
Filing Date
2021-06-24
Accepted
2021-06-24 08:40:37
Documents
4
Period of Report
2021-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120575d1_8k.htm 8-K 35052
2 EXHIBIT 10.1 tm2120575d1_ex10-1.htm EX-10.1 79348
3 EXHIBIT 99.1 tm2120575d1_ex99-1.htm EX-99.1 11662
4 GRAPHIC image_001.jpg GRAPHIC 11327
  Complete submission text file 0001104659-21-084900.txt   143312
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 211040828
SIC: 2834 Pharmaceutical Preparations